Board Justification

The goals of our compensation program are to: Align executive interests with the drivers of stockholder returns and profitable growth, Support achievement of the company’s primary business goals to have a remarkable impact on patients’ lives, Attract and retain world-class executives whose talents and contributions sustain the growth in long-term stockholder value

Board Justification

N/A

Board Justification

Change in Pension Value: $(14,755); Non-Qualified Defined Contribution Plan Earnings: $1,863,298; Earnings for Non-Qualified Defined Benefit and Non-Qualified Defined Contribution Plans: $1,608,552; Employer Contributions to Defined Contribution Plans: $80,192; Corporate automobile: $13,962; Financial planning services allowance: $10,000; Non-business-related air travel and services: $332,115; cost of seasonal gifts.

Board Justification

The award has the potential to vest at 0% to 250% of target after a 3-year performance period based on company performance in earnings per share (EPS) and relative total stockholder return (TSR). TSR performance is measured relative to a group made up of companies that are constituents in either the S&P Pharmaceutical, Biotech, and Life Science Index or the NYSE Arca Pharmaceutical Index. Dividends accrue during the performance period and are paid at vesting only to the extent that shares are earned.